Alexander Peikert

794 total citations · 1 hit paper
20 papers, 237 citations indexed

About

Alexander Peikert is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Alexander Peikert has authored 20 papers receiving a total of 237 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 6 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Alexander Peikert's work include Cardiovascular Function and Risk Factors (8 papers), Heart Failure Treatment and Management (8 papers) and Influenza Virus Research Studies (4 papers). Alexander Peikert is often cited by papers focused on Cardiovascular Function and Risk Factors (8 papers), Heart Failure Treatment and Management (8 papers) and Influenza Virus Research Studies (4 papers). Alexander Peikert collaborates with scholars based in United States, Austria and Germany. Alexander Peikert's co-authors include Scott D. Solomon, Brian Claggett, Peter Stachon, Andreas Zirlik, John J.V. McMurray, Dennis Wolf, Muthiah Vaduganathan, Constantin von zur Mühlen, Bianca Dufner and Akshay S. Desai and has published in prestigious journals such as Circulation, European Heart Journal and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Alexander Peikert

17 papers receiving 234 citations

Hit Papers

Near-universal prevalence of central adiposity in heart f... 2025 2026 2025 10 20 30
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial
    2025 35 citations Alexander Peikert, Muthiah Vaduganathan et al. European Heart Journal profile →

Peers

Alexander Peikert
Heloísa Reniers Vianna Brazil
Kaliyaperumal Velmurugan India
Sabrina Geisberger Germany
Yang Su China
Qing-Yun Hao China
Angelo Sansonetti Italy
P.H. Ducluzeau France
Andrea Impellizzeri Italy
Lamija Ferhatbegović Bosnia and Herzegovina
Heloísa Reniers Vianna Brazil
Alexander Peikert
Citations per year, relative to Alexander Peikert Alexander Peikert (= 1×) peers Heloísa Reniers Vianna

Countries citing papers authored by Alexander Peikert

Since Specialization
Citations

This map shows the geographic impact of Alexander Peikert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alexander Peikert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alexander Peikert more than expected).

Fields of papers citing papers by Alexander Peikert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alexander Peikert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alexander Peikert. The network helps show where Alexander Peikert may publish in the future.

Co-authorship network of co-authors of Alexander Peikert

This figure shows the co-authorship network connecting the top 25 collaborators of Alexander Peikert. A scholar is included among the top collaborators of Alexander Peikert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alexander Peikert. Alexander Peikert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peikert, Alexander, Marianna Fontana, Scott D. Solomon, & Thomas Thum. (2025). Left ventricular hypertrophy and myocardial fibrosis in heart failure with preserved ejection fraction: mechanisms and treatment. European Heart Journal. 47(1). 37–53. 1 indexed citations
3.
Peikert, Alexander, Muthiah Vaduganathan, Brian Claggett, et al.. (2025). Near-universal prevalence of central adiposity in heart failure with preserved ejection fraction: the PARAGON-HF trial. European Heart Journal. 46(25). 2372–2390. 35 indexed citations breakdown →
4.
Zach, David, Alexander Peikert, Peter P. Rainer, et al.. (2024). The Prognostic Value of Right Ventricular Function in Patients with Chronic Heart Failure—A Prospective Study. Journal of Clinical Medicine. 13(7). 1930–1930. 5 indexed citations
5.
6.
Skaarup, Kristoffer Grundtvig, Mats Christian Højbjerg Lassen, Daniel Modin, et al.. (2024). The relative vaccine effectiveness of high-dose vs standard-dose influenza vaccines in preventing hospitalization and mortality: A meta-analysis of evidence from randomized trials. Journal of Infection. 89(1). 106187–106187. 9 indexed citations
7.
Peikert, Alexander & Scott D. Solomon. (2024). Contemporary treatment options in heart failure with preserved ejection fraction. European Heart Journal - Cardiovascular Imaging. 25(11). 1517–1524. 2 indexed citations
8.
Peikert, Alexander, Brian Claggett, Jacob A. Udell, et al.. (2024). Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular Disease. JAMA Cardiology. 9(6). 574–574. 5 indexed citations
9.
Hegde, Sheila M., Brian Claggett, Jacob A. Udell, et al.. (2023). Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease. JAMA Network Open. 6(9). e2331284–e2331284. 1 indexed citations
10.
Peikert, Alexander, Parag Goyal, Muthiah Vaduganathan, et al.. (2023). Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction According to Polypharmacy Status. JACC Heart Failure. 11(10). 1380–1393. 13 indexed citations
11.
Peikert, Alexander, Bradley A. Bart, Muthiah Vaduganathan, et al.. (2023). Contemporary Use and Implications of Beta-Blockers in Patients With HFmrEF or HFpEF. JACC Heart Failure. 12(4). 631–644. 21 indexed citations
12.
Peikert, Alexander, Muthiah Vaduganathan, Finnian R. Mc Causland, et al.. (2022). Effects of sacubitril/valsartan versus valsartan on renal function in patients with and without diabetes and heart failure with preserved ejection fraction: insights from PARAGON‐HF. European Journal of Heart Failure. 24(5). 794–803. 19 indexed citations
13.
Peikert, Alexander, Brian Claggett, KyungMann Kim, et al.. (2022). Association of Post-Vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-Risk Cardiovascular Disease: The INVESTED Trial. European Journal of Heart Failure. 25(2). 299–310. 2 indexed citations
14.
Chatur, Safia, Muthiah Vaduganathan, Alexander Peikert, et al.. (2022). Longitudinal trajectories in renal function before and after heart failure hospitalization among patients with heart failure with preserved ejection fraction in the PARAGON‐HF trial. European Journal of Heart Failure. 24(10). 1906–1914. 21 indexed citations
15.
Stachon, Peter, Klaus Kaier, Philip Hehn, et al.. (2021). Coronary artery bypass grafting versus stent implantation in patients with chronic coronary syndrome and left main disease: insights from a register throughout Germany. Clinical Research in Cardiology. 111(7). 742–749. 2 indexed citations
16.
Kaier, Klaus, Christoph B. Olivier, Wolfgang Bothe, et al.. (2021). Use and Outcomes of Acute Treatment Strategies in Patients with Severe Aortic Valve Stenosis. Global Heart. 16(1). 91–91.
17.
Jäckel, Markus, Klaus Kaier, Jonathan Rilinger, et al.. (2021). Outcomes of female and male patients suffering from coronary artery disease. Medicine. 100(38). e27298–e27298. 2 indexed citations
18.
Peikert, Alexander, Klaus Kaier, Ingo Hilgendorf, et al.. (2019). Residual inflammatory risk in coronary heart disease: incidence of elevated high-sensitive CRP in a real-world cohort. Clinical Research in Cardiology. 109(3). 315–323. 43 indexed citations
19.
Stachon, Peter, Alexander Peikert, Nathaly Anto Michel, et al.. (2014). P2Y 6 Deficiency Limits Vascular Inflammation and Atherosclerosis in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 34(10). 2237–2245. 52 indexed citations
20.
Stachon, Peter, Alexander Peikert, A.D. Michel, et al.. (2014). 530Extracellular ATP induces atherosclerosis and vascular inflammation via purinergic receptor 2 (P2Y2) in mice. Cardiovascular Research. 103(suppl 1). S97.1–S97. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heloísa Reniers Vianna Breakdown of academic impact, for papers by Kaliyaperumal Velmurugan Breakdown of academic impact, for papers by Sabrina Geisberger Breakdown of academic impact, for papers by Yang Su Breakdown of academic impact, for papers by Qing-Yun Hao Breakdown of academic impact, for papers by Angelo Sansonetti Breakdown of academic impact, for papers by P.H. Ducluzeau Breakdown of academic impact, for papers by Andrea Impellizzeri Breakdown of academic impact, for papers by Lamija Ferhatbegović
Rankless by CCL
2026